CD4 and metabolic dysfunction-associated steatohepatitis: Moreover, we show that there is a more chaotic developmental path with different pathogenic endpoints and an increase in multicytokine-producing CD4+ T cells in NASH patients that could be one of the causes of the chronic liver inflammation typical of these patients.